Company / Current Assets
Celularity Inc Current Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$12.3M
FY2025
5-year range
$12.3M / $59.1M
FY2021-FY2025
Trend
-40.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $20M to $12M over the past 2 years.
Based on SEC 10-K filings.
$12M in FY2025 with a 3-year CAGR of -28.4%.
Declined from $20M to $12M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -28.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -28.4%, indicating a declining trend.
- In FY2025, current assets decreased 40.1% year-over-year.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.3M | -40.1% |
| FY2024 | $20.6M | +3.9% |
| FY2023 | $19.8M | -40.9% |
| FY2022 | $33.5M | -43.3% |
| FY2021 | $59.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026